Skip to content

Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method

Comparison of the Use of VAC (Vacuum Assisted Closure) System in Transplants of Leg Ulcers Versus Usual Dressing Method. A Monocentric, Prospective, Randomized, Parallel Groups Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02509533
Enrollment
36
Registered
2015-07-28
Start date
2010-09-30
Completion date
2014-03-31
Last updated
2015-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leg Ulcer

Keywords

Vacuum Assisted Closure

Brief summary

To evaluate the VAC (Vacuum Assisted Closure) therapy in transplants of leg ulcers versus usual dressing method. The VAC Therapy system consists of: * A unit delivering a precise under atmospheric pressure, controlled and regulated in the wound site, * Consumables necessary for the implementation of the dressing, * Collecting tanks exudates with gel. VAC therapy is a system using negative pressure. It is known to be efficient into care of chronic wounds and ulcerous wounds by increasing the cicatrisation. This system is systematically used into the dermatology unit of the CHU of Saint-Etienne after transplants of leg ulcers, but no data confirms the interest of this method compared to usual dressing method. This study will provide this data.

Interventions

DEVICEV.A.C.®

Patients received V.A.C.® Therapy (KCI medical) after a transplants of leg ulcers.

DEVICEdressing

Patients received usual dressing method (compresses) after a transplants of leg ulcers

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient hospitalized into the dermatology unit * patient with an evolutive leg ulcer since more than 1 month * signed informed consent

Exclusion criteria

* known allergy to one of dressings used in this study * patient with a non-treated osteomyelitis * patient with tumoral tissues into the wound * patient with raw organ or raw blood vessels * patient with an anticoagulation treatment with a potentially hemorrhagic curative dose * patient having hemostasis problems that can lead to hemorrhagic exudates

Design outcomes

Primary

MeasureTime frameDescription
Percentage of healing between VAC system and compresses for all types of leg ulcers1 month after the transplantNumber of patients having a wound at least 50% of the grafted area between VAC system and compresses

Secondary

MeasureTime frameDescription
Percentage of healing between VAC system and compresses for all types of leg ulcers3 months after the transplantNumber of patients having a wound at least 50% of the grafted area between VAC system and compresses
Evolution of the pain by Analogic Visual Scale.day 0 : just before the transplantPain score as measured by visual analog scale between VAC system and compresses
Evolution of the pain by Analogic Visual ScaleMonth 1Pain score as measured by visual analog scale between VAC system and compresses
Quality of life questionnaire score.day 0 : just before the transplantQuality of life questionnaire score between VAC system and compresses
Cost of the treatment.Month 3Cost of the treatment, between VAC system and compresses This coast includes costs of consumables, hospitalisation days and nursing costs

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026